Cargando…
KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
BACKGROUND: Cardiovascular diseases have become the leading cause of death worldwide, and cardiac hypertrophy is the core mechanism underlying cardiac defect and heart failure. However, the underlying mechanisms of cardiac hypertrophy are not fully understood. Here we investigated the roles of Kalli...
Autores principales: | Wang, Yi, Liao, Hongjuan, Wang, Yueheng, Zhou, Jinlin, Wang, Feng, Xie, Yingxin, Zhao, Kun, Gao, Weinian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167988/ https://www.ncbi.nlm.nih.gov/pubmed/34059001 http://dx.doi.org/10.1186/s12872-021-02053-y |
Ejemplares similares
-
Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling
por: Gao, Weinian, et al.
Publicado: (2020) -
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
por: Zhao, Ting, et al.
Publicado: (2021) -
mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013) -
Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
por: Tong, Wing-Hang, et al.
Publicado: (2022) -
miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
por: Li, Z, et al.
Publicado: (2017)